http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2357620-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-538 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
| filingDate | 2006-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d87ac1a4bf277160d65d22a827915df3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1abfa43468cc8dff0cdce952751c5fbd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd1640e553021a4dd366d2afbf228236 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc820d89200709af6b5978dc2135835d |
| publicationDate | 2011-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2357620-T3 |
| titleOfInvention | NEW BETAMIMETICS OF PROLONGED ACTION FOR THE TREATMENT OF DISEASES OF THE RESPIRATORY ROUTES. |
| abstract | A means a bivalent moiety chosen from the group consisting of -CR 4 R 5 -O-, -CH = CH- and -CH2-CH2-, preferably -CR 4 R 5 -O-; R 1 means -C 1-4 alkyl; R 2 and R 3 are the same or different and mean H, C 1-4 alkyl, C 2-4 alkenyl, C 2-4 alkynyl, C 3-6 cycloalkyl, C 1-4 haloalkyl, -O-C 1-4 haloalkyl, halogen, OH, CN, NO2, C2-4-OH alkyl, -O-C1-4 alkyl, COOH or COO-C1-4 alkyl, or R 2 and R 3 together form a bivalent moiety selected from -O-CR 4 R 5 -O -, -O-CR 4 R 5 -NR 6 and -CH = CH-CH = CH-; R 4 means H or C 1-4 alkyl; R 5 means H or C 1-4 alkyl; R 6 means H or C 1-4 alkyl, optionally in the form of individual enantiomers, of mixtures of the individual enantiomers or of racemates, optionally in the form of their pharmaceutically safe acid addition salts, as well as optionally in the form of their solvates and / or hydrates |
| priorityDate | 2005-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 225.